Tag Archives: Anti-Infective Drugs Advisory Committee meeting

Basilea Pharmaceutica Ltd. announces that the U.S. FDA sets Anti-Infective Drugs Advisory Committee meeting on NDA for the investigational antifungal isavuconazole

Posted on 24, November 2014 by

Basel, Switzerland, 24-11-2014 — /EuropaWire/ — Basilea Pharmaceutica Ltd. (SIX: BSLN) reports today that the U.S. Food and Drug Administration (FDA) announced a public meeting of the Anti-Infective Drugs Advisory Committee to discuss the New Drug Application (NDA) for the investigational … Read the full press release →

Posted in Healthcare, Pharma & Biotech, Switzerland

Tagged , , ,